APX -11.71%: the digital marketing AI company fell below $3/sh for the first time since 2017 today following a downgrade to guidance. Just 6 weeks ago the company was talking to a stronger second half, though revenue was still expected to fall short of FY21 levels. Today, the company said conditions had failed to improve as expected and further uncertainty remains into the end of the year, providing guidance of $US375-395m for revenue, ~14% below FY21 and 5% below consensus. Margins have also been impacted with a lower portion of sales coming from high-margin work. It’s been a challenging period for Appen with EBITDA now expected to fall 80% in a year and digital ad revenue going backwards.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
Close
Eli Lilly & Co (LLY US) v Novo Nordisk (NVO US)
Close
Gerrish: The correction is done, we’re positioning for what comes next
Close
Friday 6th June – Dow off -108pts, SPI down -13pts
Close
MM has no interest in APX
Add To Hit List
Related Q&A
McMillan Shakespeare Ltd (MMS)
NEC and APX
Appen and Nuix
MCMILLAN SHAKESPEARE LIMITED
Appen Ltd (APX)
Thoughts on MMS?
Pullback on MMS and SIQ
Thoughts on Appen (APX) and CSR
Thoughts on mff
MMS view going forward
Sigma and Chemist Warehouse merger
Any thoughts on Meteoric Resources (MEI)?
Thoughts on MMS and SIQ share price movements
MM call to ‘Cut Losers’ like MFG, KGN, APX
Does MM prefer MMS or SIQ?
Updated view on few battered up stocks?
Appen (APX)
New CBA Hybrid + APX & CSL
Relevant suggested news and content from the site

Video
WATCH
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
FY26 is shaping up as a year where strategic portfolio positioning will matter more than ever. Hear from James Gerrish & Shawn Hickman as they detail MM's current views.


chart
Eli Lilly & Co (LLY US) v Novo Nordisk (NVO US)

Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.

Podcast
LISTEN
Friday 6th June – Dow off -108pts, SPI down -13pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.